EVOK - Evoke Pharma Inc
IEX Last Trade
4.22
-0.090 -2.133%
Share volume: 19,956
Last Updated: Fri 30 Aug 2024 02:17:22 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$4.31
-0.09
-2.09%
Summary score
42%
Profitability
50%
Dept financing
14%
Liquidity
50%
Performance
40%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
63.82%
Return on assets
-32.49%
Return on sales
0%
Return on invested capital
151.23%
Total debt ratio
44.1%
Debt ratio change over timeo
-0.53%
Current Ratio
5.15%
Quick Ratio
0%
Cash Position Ratio
4.95%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
434.86%
Return on assets
-41.88%
Return on sales
0%
Return on invested capital
92.52%
Total debt ratio
50.61%
Debt ratio change over timeo
-0.5%
Current Ratio
2.59%
Quick Ratio
0%
Cash Position Ratio
2.36%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
1864.56%
Return on assets
-84.25%
Return on sales
0%
Return on invested capital
106.06%
Total debt ratio
104.52%
Debt ratio change over time
-0.06%
Current Ratio
1.23%
Quick Ratio
0%
Cash Position Ratio
1.2%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-65.12%
Return on assets
-144.11%
Return on sales
0%
Return on invested capital
109.51%
Total debt ratio
-52.77%
Debt ratio change over time
-0.53%
Current Ratio
5.38%
Quick Ratio
0%
Cash Position Ratio
5.13%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | EVOK | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 63.82% | 17.45% | 19.89% | 4.69% |
| Return on assets | -32.49% | 3.37% | 11.41% | 3.35% |
| Return on sales | 0% | 23.96% | 42.05% | 25.96% |
| Return on invested capital | 151.23% | 5.2% | -272.99% | 4.37% |
| Profitability | 50% | 29% | 58% | 25% |
| Total debt ratio | 44.1% | 77% | 53.92% | 57.66% |
| Debt ratio change over time | -0.53% | 0.36% | -1.16% | 10.77% |
| Dept financing | 14% | 26% | 18% | 44% |
| Current Ratio | 2.59% | 1.16% | 1.05% | 1.27% |
| Quick Ratio | 0% | 0.89% | 0.77% | 1.01% |
| Cash Position Ratio | 2.36% | 0.17% | 0.31% | 0.53% |
| Liquididy | 50% | 28% | 23% | 36% |
| Short-term ratios | EVOK | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 434.86% | 44.06% | 17.3% | 6.24% |
| Return on assets | -41.88% | 3.88% | 9.33% | 3.22% |
| Return on sales | 0% | 27.04% | 40.02% | 24.93% |
| Return on invested capital | 92.52% | 9.69% | -224.06% | 4.96% |
| Profitability | 50% | 32% | 51% | 26% |
| Total debt ratio | 50.61% | 91.8% | 55.88% | 61.39% |
| Debt ratio change over time | -0.5% | 8.35% | -0.88% | 10.36% |
| Dept financing | 14% | 45% | 15% | 42% |
| Current Ratio | 2.59% | 1.16% | 1.05% | 1.27% |
| Quick Ratio | 0% | 0.89% | 0.77% | 1.01% |
| Cash Position Ratio | 2.36% | 0.17% | 0.31% | 0.53% |
| Liquididy | 50% | 35% | 32% | 43% |